万孚生物 - Financials

万孚生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
+Revenue	3.1B	2.8B	5.7B	3.4B	2.8B	2.1B	1.6B	1.1B	547.0M	429.0M	365.0M	248.0M	227.0M	183.0M
Revenue Growth %	10.8%	-51.3%	69.0%	19.6%	35.7%	25.6%	44.1%	109.3%	27.5%	17.5%	47.2%	9.3%	24.0%	--
Total Revenue	3.1B	2.8B	5.7B	3.4B	2.8B	2.1B	1.6B	1.1B	547.0M	429.0M	365.0M	248.0M	227.0M	183.0M
Cost Of Revenue	1.1B	1.0B	2.7B	1.4B	871.0M	721.0M	644.0M	444.0M	172.0M	142.0M	128.0M	105.0M	112.0M	92.6M
+Gross Profit	2.0B	1.7B	2.9B	2.0B	1.9B	1.4B	1.0B	701.0M	375.0M	287.0M	237.0M	143.0M	115.0M	90.4M
Gross Margin %	64.1%	62.6%	51.8%	58.5%	69.0%	65.2%	61.0%	61.2%	68.6%	66.9%	64.9%	57.7%	50.7%	49.4%
Total Operating Cost	2.5B	2.3B	4.4B	2.8B	2.1B	1.6B	1.3B	919.0M	399.0M	312.0M	277.0M	204.0M	197.0M	160.0M
Selling Expenses	683.0M	650.0M	930.0M	644.0M	631.0M	498.0M	358.0M	238.0M	134.0M	96.5M	83.8M	47.6M	32.7M	25.6M
Admin Expenses	222.0M	227.0M	228.0M	266.0M	189.0M	158.0M	143.0M	110.0M	102.0M	74.9M	62.4M	50.2M	45.4M	38.6M
Rd Expenses	412.0M	378.0M	419.0M	391.0M	279.0M	160.0M	137.0M	91.6M	--	--	--	--	--	--
Finance Expenses	2.2M	-6.4M	-698,000	48.9M	28.0M	-4.7M	-6.0M	21.0M	-11.6M	-5.8M	672,100	280,300	2.9M	3.1M
+Operating Income	637.0M	549.0M	1.4B	692.0M	740.0M	509.0M	412.0M	261.0M	159.0M	122.0M	91.5M	44.0M	29.9M	23.1M
Operating Margin %	20.8%	19.9%	24.1%	20.6%	26.3%	24.6%	25.0%	22.8%	29.1%	28.4%	25.1%	17.8%	13.2%	12.6%
Non Operating Income	1.5M	3.5M	3.0M	2.8M	296,300	536,700	615,300	7.7M	16.1M	22.7M	23.4M	25.8M	12.6M	13.4M
Non Operating Expenses	8.8M	11.9M	6.2M	14.2M	9.5M	6.2M	3.5M	1.6M	556,800	381,600	284,000	100,200	1,700	18,000
Investment Income	1.9M	31.1M	59.8M	47.5M	31.9M	-606,600	20.6M	2.9M	10.3M	4.7M	3.5M	--	--	--
Fair Value Change Income	29.6M	14.8M	12.8M	10.6M	237,000	160,700	--	--	--	--	-107,900	--	--	--
Asset Disposal Income	759,600	80,100	-10.4M	-5,700	181,800	-936,400	-76,200	-20,500	--	--	--	--	--	--
Asset Impairment Loss	12.4M	11.5M	79.0M	5.9M	116.0M	37.5M	4.5M	8.4M	-1.1M	2.8M	1.2M	216,200	3.5M	-502,500
Other Income	24.9M	45.9M	55.2M	57.1M	28.5M	29.2M	31.9M	31.7M	--	--	--	--	--	--
Income Before Tax	629.0M	541.0M	1.4B	680.0M	731.0M	503.0M	409.0M	267.0M	174.0M	144.0M	115.0M	69.7M	42.4M	36.4M
Income Tax	64.2M	53.3M	174.0M	47.9M	114.0M	76.0M	62.6M	41.6M	28.7M	18.8M	16.2M	10.7M	4.5M	4.8M
+Net Income	565.0M	487.0M	1.2B	633.0M	617.0M	427.0M	347.0M	225.0M	146.0M	125.0M	98.4M	59.0M	37.9M	31.7M
Net Margin %	18.4%	17.6%	20.9%	18.8%	21.9%	20.6%	21.0%	19.7%	26.7%	29.1%	26.9%	23.8%	16.7%	17.3%
Net Income Attributable	562.0M	488.0M	1.2B	634.0M	634.0M	387.0M	308.0M	211.0M	145.0M	125.0M	98.4M	59.0M	37.9M	31.7M
Minority Interest	3.6M	-196,400	-6.9M	-1.9M	-17.4M	39.6M	38.8M	14.4M	519,800	--	--	--	-29,400	1,700
Eps Basic	1.21	1.10	2.71	1.43	1.44	1.14	0.92	0.67	0.82	0.81	1.49	0.89	0.57	--
Eps Diluted	1.21	1.10	2.71	1.43	1.44	1.14	0.92	0.66	0.82	0.81	1.49	0.89	0.57	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash And Equivalents	829.0M	840.0M	1.2B	996.0M	1.4B	881.0M	1.1B	473.0M	577.0M	476.0M	152.0M	104.0M	73.1M	31.5M
Trading Financial Assets	1.3B	722.0M	938.0M	573.0M	103.0M	99.5M	--	--	--	--	--	--	--	--
Accounts Receivable	1.1B	598.0M	540.0M	498.0M	269.0M	419.0M	358.0M	246.0M	58.0M	36.5M	23.4M	21.4M	32.5M	39.3M
Notes Receivable	14.6M	1.7M	806,400	3.5M	608,700	457,200	790,000	1.1M	--	--	--	--	--	--
Notes And Accounts Receivable	1.1B	600.0M	541.0M	502.0M	270.0M	419.0M	359.0M	247.0M	58.0M	36.5M	23.4M	21.4M	32.5M	39.3M
Prepayments	17.9M	17.3M	26.6M	53.5M	35.2M	38.9M	26.6M	29.8M	5.5M	4.2M	3.1M	5.1M	5.1M	11.8M
Inventory	360.0M	351.0M	400.0M	386.0M	377.0M	224.0M	166.0M	131.0M	79.3M	49.0M	51.4M	45.2M	40.8M	48.2M
Total Current Assets	3.8B	3.2B	3.4B	2.6B	2.3B	1.7B	1.8B	957.0M	726.0M	569.0M	233.0M	179.0M	156.0M	136.0M
Long Term Equity Investment	425.0M	406.0M	364.0M	334.0M	282.0M	159.0M	28.8M	3.9M	3.8M	3.4M	3.4M	--	--	--
Fixed Assets	--	1.0B	964.0M	852.0M	520.0M	426.0M	370.0M	249.0M	220.0M	151.0M	146.0M	133.0M	128.0M	94.4M
Fixed Assets Total	1.5B	1.0B	964.0M	852.0M	520.0M	426.0M	370.0M	249.0M	220.0M	151.0M	146.0M	133.0M	128.0M	94.4M
Construction In Progress	--	291.0M	199.0M	16.4M	156.0M	79.9M	26.7M	4.9M	3.7M	490,400	717,400	3.1M	--	16.1M
Construction In Progress Total	5.1M	291.0M	199.0M	16.4M	156.0M	79.9M	26.7M	4.9M	3.7M	490,400	717,400	3.1M	--	16.1M
Intangible Assets	206.0M	195.0M	204.0M	208.0M	180.0M	156.0M	110.0M	106.0M	14.6M	13.9M	13.6M	12.2M	10.2M	10.1M
Long Term Deferred Expenses	16.1M	13.3M	13.3M	15.7M	15.7M	14.8M	17.7M	7.9M	69,400	60,800	--	--	--	--
Total Non Current Assets	3.4B	2.5B	3.0B	2.3B	2.0B	1.2B	918.0M	738.0M	280.0M	230.0M	174.0M	158.0M	147.0M	126.0M
Total Assets	7.2B	5.8B	6.3B	4.9B	4.3B	2.9B	2.7B	1.7B	1.0B	799.0M	407.0M	336.0M	303.0M	262.0M
Short Term Borrowings	755,400	--	204.0M	17.1M	85.0M	4.0M	30.8M	19.5M	4.0M	--	--	--	45.0M	51.5M
Accounts Payable	288.0M	130.0M	320.0M	400.0M	300.0M	156.0M	150.0M	140.0M	50.9M	34.8M	26.3M	26.1M	27.3M	29.8M
Advance Receipts	--	--	--	--	--	42.2M	28.1M	28.2M	25.8M	8.7M	11.5M	11.4M	1.6M	5.2M
Contract Liabilities	77.1M	72.9M	236.0M	80.5M	97.7M	--	--	--	--	--	--	--	--	--
Total Current Liabilities	821.0M	484.0M	1.1B	792.0M	793.0M	443.0M	524.0M	380.0M	140.0M	85.9M	80.8M	78.3M	101.0M	101.0M
Long Term Borrowings	--	--	--	--	--	--	--	114.0M	--	--	--	--	--	--
Total Non Current Liabilities	683.0M	673.0M	623.0M	560.0M	519.0M	40.1M	16.4M	124.0M	10.7M	12.0M	12.8M	16.6M	19.1M	16.9M
Total Liabilities	1.5B	1.2B	1.8B	1.4B	1.3B	483.0M	540.0M	505.0M	151.0M	97.9M	93.6M	94.9M	120.0M	118.0M
Paid In Capital	481.0M	445.0M	445.0M	445.0M	343.0M	343.0M	343.0M	178.0M	176.0M	88.0M	66.0M	66.0M	66.0M	40.0M
Capital Reserve	1.5B	766.0M	776.0M	787.0M	866.0M	863.0M	876.0M	349.0M	291.0M	379.0M	85.5M	85.5M	85.5M	11.9M
Surplus Reserve	261.0M	261.0M	261.0M	261.0M	201.0M	139.0M	96.1M	69.4M	50.6M	33.1M	20.6M	10.2M	4.0M	10.0M
Retained Earnings	3.5B	3.2B	2.9B	1.8B	1.4B	949.0M	680.0M	494.0M	329.0M	201.0M	141.0M	79.6M	26.9M	82.5M
Minority Equity	95.9M	98.7M	194.0M	151.0M	151.0M	237.0M	217.0M	161.0M	12.1M	--	--	--	--	29,400
Equity Attributable	5.6B	4.5B	4.3B	3.4B	2.8B	2.2B	1.9B	1.0B	843.0M	701.0M	313.0M	241.0M	182.0M	145.0M
Total Equity	5.7B	4.6B	4.5B	3.5B	3.0B	2.5B	2.2B	1.2B	855.0M	701.0M	313.0M	241.0M	182.0M	145.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011
Cash From Sales	2.5B	2.6B	5.8B	3.2B	3.1B	2.1B	1.6B	1.1B	566.0M	423.0M	371.0M	278.0M	238.0M	181.0M
Tax Refunds Received	7.6M	17.0M	14.2M	17.0M	18.6M	5.8M	5.0M	506,100	478,200	305,700	--	--	--	--
Total Operating Cash Inflow	2.6B	2.7B	6.0B	3.3B	3.2B	2.2B	1.7B	1.1B	586.0M	448.0M	390.0M	314.0M	269.0M	219.0M
Cash Paid For Goods	760.0M	867.0M	2.5B	1.2B	971.0M	922.0M	681.0M	443.0M	195.0M	110.0M	107.0M	87.0M	92.9M	107.0M
Cash Paid To Employees	839.0M	832.0M	911.0M	903.0M	593.0M	405.0M	323.0M	236.0M	138.0M	112.0M	76.6M	47.7M	36.4M	27.1M
Taxes Paid	151.0M	178.0M	207.0M	165.0M	161.0M	135.0M	126.0M	75.1M	41.2M	26.4M	24.0M	18.3M	18.2M	14.2M
Total Operating Cash Outflow	2.2B	2.4B	4.3B	2.7B	2.1B	1.9B	1.5B	953.0M	474.0M	316.0M	286.0M	213.0M	195.0M	195.0M
Operating Cash Flow	362.0M	329.0M	1.7B	665.0M	1.1B	310.0M	248.0M	169.0M	112.0M	132.0M	104.0M	101.0M	74.8M	23.8M
Total Investing Cash Inflow	4.5B	3.2B	4.9B	5.9B	6.0B	4.1B	2.4B	546.0M	1.6B	770.0M	1.1B	--	--	4,600
Total Investing Cash Outflow	5.5B	3.4B	6.4B	6.7B	7.0B	4.4B	2.6B	985.0M	1.6B	842.0M	1.1B	24.2M	23.8M	20.8M
Investing Cash Flow	-1.0B	-113.0M	-1.6B	-785.0M	-1.0B	-332.0M	-210.0M	-439.0M	-33.0M	-72.2M	-29.4M	-24.2M	-23.8M	-20.7M
Cash From Borrowings	--	--	225.0M	22.7M	683.0M	14.4M	33.1M	137.0M	2.0M	--	--	--	59.0M	64.0M
Dividends And Interest Paid	202.0M	233.0M	143.0M	175.0M	92.4M	83.2M	99.6M	31.1M	3,400	52.8M	26.4M	765,800	2.9M	3.3M
Debt Repayments	1,304	204.0M	22.8M	90.2M	3.0M	106.0M	71.6M	4.0M	--	--	--	45.0M	65.5M	55.5M
Total Financing Cash Inflow	883.0M	76.9M	317.0M	105.0M	720.0M	156.0M	849.0M	237.0M	6.9M	322.0M	--	4.2M	59.0M	79.0M
Total Financing Cash Outflow	244.0M	619.0M	281.0M	375.0M	218.0M	272.0M	217.0M	65.3M	129.0M	61.8M	26.4M	45.8M	72.7M	59.2M
Financing Cash Flow	639.0M	-542.0M	35.3M	-271.0M	503.0M	-116.0M	632.0M	172.0M	-122.0M	260.0M	-26.4M	-41.5M	-13.7M	19.8M
Net Change In Cash	-11.5M	-321.0M	165.0M	-412.0M	528.0M	-137.0M	672.0M	-103.0M	-28.4M	322.0M	48.3M	35.0M	37.4M	22.8M
Ending Cash Balance	828.0M	840.0M	1.2B	995.0M	1.4B	879.0M	1.0B	343.0M	446.0M	474.0M	152.0M	104.0M	68.8M	31.5M
Capex	318.0M	433.0M	583.0M	456.0M	420.0M	179.0M	131.0M	113.0M	88.0M	28.9M	27.0M	24.2M	23.8M	20.8M